Symptoms of Insulinoma
Insulinomas present with two distinct categories of hypoglycemic symptoms: neuroglycopenic symptoms (confusion, visual disturbances, weakness, seizures, loss of consciousness) and adrenergic/autonomic symptoms (sweating, tremor, palpitations, tachycardia), all of which are relieved by sugar intake. 1
Core Clinical Presentation
The hallmark of insulinoma is Whipple's triad, which must be present for diagnosis 2:
- Symptoms of hypoglycemia
- Documented plasma glucose <55 mg/dL (≤0.45 g/L)
- Resolution of symptoms after glucose administration
Specific Symptom Categories
Neuroglycopenic Symptoms (Brain Glucose Deprivation)
These occur when the brain is deprived of adequate glucose:
- Loss of consciousness (68% of patients) 3
- Confusion and altered mental status
- Seizures - can be the presenting symptom 4, 2
- Visual disturbances
- Weakness and fatigue
- Vertigo/dizziness (56% of patients) 3
- In severe cases: coma 5
Adrenergic/Autonomic Symptoms (Catecholamine Response)
These result from the body's compensatory response to hypoglycemia:
- Sweating/diaphoresis (59% of patients) 3
- Tremor
- Palpitations and tachycardia
- Anxiety and irritability 2
- Uneasiness 6
Critical Timing Patterns
Symptoms characteristically occur during fasting states or between meals and are promptly relieved by eating, particularly carbohydrate-rich foods 1, 6. This pattern distinguishes insulinoma from reactive hypoglycemia, which occurs after meals.
The time from symptom onset to diagnosis is highly variable, ranging from 1 month to 17 years, with an average of 33.4 months in recent series 1, 3. This diagnostic delay occurs because symptoms are often initially attributed to neurological or psychiatric conditions 4.
Important Clinical Nuances
Malignant insulinomas may present with more severe and prolonged symptoms due to greater insulin and proinsulin production from metastatic tumor burden, though severity doesn't strictly correlate with tumor size 1.
In genetic syndromes like MEN-1, insulinomas typically present 10 years earlier (age 30-35 years vs. 50-60 years for sporadic cases) and can occur as early as age 5 7.
Common Diagnostic Pitfalls
- Misdiagnosis as primary neurological disease (epilepsy, stroke) is common when neuroglycopenic symptoms predominate 4
- Symptoms may be dismissed as anxiety or panic attacks when adrenergic symptoms are prominent
- The insidious course and ambiguous presentation often lead to extensive workups at multiple facilities before diagnosis 6, 8
The psychological impact on patients, families, and healthcare teams should not be underestimated, as the unpredictable nature of hypoglycemic episodes significantly impairs quality of life and can cause substantial anxiety 1.